These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 29150054)

  • 61. SOP 04: Data collection forms (case report forms).
    Onkologie; 2003 Oct; 26 Suppl 6():15-22. PubMed ID: 23570180
    [No Abstract]   [Full Text] [Related]  

  • 62. Measurement error in clinical perinatal data.
    Villar J; Kestler E; Pareja G
    Am J Obstet Gynecol; 1989 Feb; 160(2):380-2. PubMed ID: 2916621
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Applicability, reliability, sensitivity, and specificity of six Brighton Collaboration standardized case definitions for adverse events following immunization.
    Kohl KS; Magnus M; Ball R; Halsey N; Shadomy S; Farley TA
    Vaccine; 2008 Nov; 26(50):6349-60. PubMed ID: 18805456
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Applicability of the GAIA Maternal and Neonatal Outcome Case Definitions for the Evaluation of Adverse Events Following Vaccination in Pregnancy in High-income Countries.
    Watson G; Dodd C; Munoz FM; Eckert LO; Jones CE; Buttery JP; Yildirim IB; Kachikis A; Heath PT; Schlaudecker EP; Bond NH; Santarcangelo PL; Wilcox CR; Bellamy K; Elmontser M; Sienas L; Simon R; Khalil A; Townsend R; Sturkenboom M; Black S
    Pediatr Infect Dis J; 2021 Dec; 40(12):1127-1134. PubMed ID: 34596623
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adverse events following immunization: real causality and myths.
    Principi N; Esposito S
    Expert Opin Drug Saf; 2016 Jun; 15(6):825-35. PubMed ID: 26986067
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Vaccine safety surveillance in Kenya using GAIA standards: A feasibility assessment of existing national and subnational research and program systems.
    Izulla P; Wagai JN; Akelo V; Ombeva A; Okeri E; Onyango D; Omore R; Fuller S; Khagayi S; Were J; Anderson SA; Wong HL; Tippett Barr BA
    Vaccine; 2023 Sep; 41(39):5722-5729. PubMed ID: 37550143
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data.
    Tavares Da Silva F; Gonik B; McMillan M; Keech C; Dellicour S; Bhange S; Tila M; Harper DM; Woods C; Kawai AT; Kochhar S; Munoz FM;
    Vaccine; 2016 Dec; 34(49):6057-6068. PubMed ID: 27431422
    [No Abstract]   [Full Text] [Related]  

  • 68. SOP 08: Reporting of adverse events.
    Onkologie; 2003 Oct; 26 Suppl 6():41-2. PubMed ID: 23570185
    [No Abstract]   [Full Text] [Related]  

  • 69. Reporting of adverse events following immunizations in Ghana - Using disproportionality analysis reporting ratios.
    Ankrah DNA; Darko DM; Sabblah G; Mantel-Teeuwisse A; Leufkens HMG
    Hum Vaccin Immunother; 2018 Jan; 14(1):172-178. PubMed ID: 29172941
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Major Birth Defects after Vaccination Reported to the Vaccine Adverse Event Reporting System (VAERS), 1990 to 2014.
    Moro PL; Cragan J; Lewis P; Sukumaran L
    Birth Defects Res; 2017 Jul; 109(13):1057-1062. PubMed ID: 28762675
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of gender on reporting of MMR adverse events in Saudi Arabia.
    Khalil MK; Al-Mazrou YY; Al-Ghamdi YS; Tumsah S; Al-Jeffri M; Meshkhas A
    East Mediterr Health J; 2003; 9(1-2):152-8. PubMed ID: 15562745
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Congenital anomalies: Case definition and guidelines for data collection, analysis, and presentation of immunization safety data.
    DeSilva M; Munoz FM; Mcmillan M; Kawai AT; Marshall H; Macartney KK; Joshi J; Oneko M; Rose AE; Dolk H; Trotta F; Spiegel H; Tomczyk S; Shrestha A; Kochhar S; Kharbanda EO;
    Vaccine; 2016 Dec; 34(49):6015-6026. PubMed ID: 27435386
    [No Abstract]   [Full Text] [Related]  

  • 73. Descriptive epidemiology of adverse events after immunization: reports to the Vaccine Adverse Event Reporting System (VAERS), 1991-1994.
    Braun MM; Ellenberg SS
    J Pediatr; 1997 Oct; 131(4):529-35. PubMed ID: 9386653
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The science of evaluation of adverse events associated with vaccination.
    Halsey NA
    Semin Pediatr Infect Dis; 2002 Jul; 13(3):205-14. PubMed ID: 12199617
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Impact of maternal vaccination timing and influenza virus circulation on birth outcomes in rural Nepal.
    Kozuki N; Katz J; Englund JA; Steinhoff MC; Khatry SK; Shrestha L; Kuypers J; Mullany LC; Chu HY; LeClerq SC; Tielsch JM
    Int J Gynaecol Obstet; 2018 Jan; 140(1):65-72. PubMed ID: 28984909
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Levels of low birth-weight in Europe: registration problems and effects of medical interventions].
    Alexander S; Boutsen M; Kittel F; Buekens P
    Rev Epidemiol Sante Publique; 1995; 43(3):272-80. PubMed ID: 7784676
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Guidelines for submitting adverse event reports for publication.
    Kelly WN; Arellano FM; Barnes J; Bergman U; Edwards RI; Fernandez AM; Freedman SB; Goldsmith DI; Huang KA; Jones JK; McLeay R; Moore N; Stather RH; Trenque T; Troutman WG; van Puijenbroek E; Williams F; Wise RP; ;
    Drug Saf; 2007; 30(5):367-73. PubMed ID: 17472416
    [TBL] [Abstract][Full Text] [Related]  

  • 78. A global survey of adverse event following immunization surveillance systems for pregnant women and their infants.
    Cassidy C; MacDonald NE; Steenbeek A; Ortiz JR; Zuber PL; Top KA
    Hum Vaccin Immunother; 2016 Aug; 12(8):2010-2016. PubMed ID: 27159639
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Neonatal infections: Case definition and guidelines for data collection, analysis, and presentation of immunisation safety data.
    Vergnano S; Buttery J; Cailes B; Chandrasekaran R; Chiappini E; Clark E; Cutland C; de Andrade SD; Esteves-Jaramillo A; Guinazu JR; Jones C; Kampmann B; King J; Kochhar S; Macdonald N; Mangili A; de Menezes Martins R; Velasco Muñoz C; Padula M; Muñoz FM; Oleske J; Sanicas M; Schlaudecker E; Spiegel H; Subelj M; Sukumaran L; Tagbo BN; Top KA; Tran D; Heath PT;
    Vaccine; 2016 Dec; 34(49):6038-6046. PubMed ID: 27491687
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Safety of tetanus, diphtheria, and acellular pertussis vaccination among pregnant active duty U.S. military women.
    Hall C; Abramovitz LM; Bukowinski AT; Ricker AA; Khodr ZG; Gumbs GR; Wells NY; Conlin AMS
    Vaccine; 2020 Feb; 38(8):1982-1988. PubMed ID: 31952872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.